Tuesday March 19, 2019

Maharashtra Governor calls for developing drugs against lifestyle ailments

0
//
www.youtube.com

NewsGram Staff Writer

Mumbai: Maharashtra Governor CV Rao on Saturday called upon the Indian pharmaceutical industry to develop drugs to combat lifestyle diseases like diabetes, hypertension, cardiovascular ailments and tuberculosis.

Speaking at the golden jubilee celebrations of the Organisation of Pharmaceutical Producers of India (OPPI) in Mumbai, the governor said lifestyle diseases were playing havoc in the country.

Rao urged the research-based pharma industry to lay renewed thrust on research and innovation and significantly hike investments in drug development and research activities.

“The senior population in India, which is currently 90 million, would touch around 173 million in the next 10 years and the OPPI must make comprehensive plans for their physical, financial, emotional safety and well-being,” Rao said.

He lauded the OPPI for “improving the life quality of Indian and also from other under-developed and developing countries” besides partnering India’s growth and development vide technical collaborations, disease awareness programs, patient-access initiatives and drug safety efforts.

To mark the OPPI milestone, Rao felicitated eminent people like Dr Tarun Gupta, Dr J N Banerjee, Prof RD Joshi, Ranjit Shahani, Dr Prathap Reddy, Dr D B Gupta for their outstanding contributions to OPPI.

OPPI is an organisation of research-based pharma companies in the country with members like Abbott, Bayer’s, GSK, Merck, Novartis, Pfizer, Sanofi, etc.

(With inputs from IANS)

Next Story

Joint Surgery May Spike up Blood Sugar Levels in Diabetics

Haemoglobin A1c above 6.59 for people with insulin-dependent diabetes and 6.6 without the condition was associated with an elevated risk for post-operative hyperglycemia

0
Knee Joint. Pixabay.

People with diabetes who undergo joint replacement surgery are at higher risk of experiencing elevated blood sugar levels after the operation, increasing their chances of developing infections and other complications, a new study suggested.

Patients with insulin-dependent diabetes were more than five times as likely as those without the condition to develop hyperglycemia, or high blood sugar, after surgery, said researchers, including Bradford Waddell from the Hospital for Special Surgery (HSS) in the US.

“If your patient comes in with diabetes and is dependent on insulin, you need to be more cognizant of controlling their blood sugar in the perioperative period because they’re at higher risk,” said Waddell.

For the study, presented at the 2019 annual meeting of the American Academy of Orthopaedic Surgeons, the team reviewed medical charts of 773 men and women who had undergone total hip or knee replacement surgeries between 2011 and 2016.

Of those, 437 had insulin-dependent diabetes, while 336 had not the condition. It included patients with a diagnosis of diabetes whose blood sugar was being controlled using the hormone insulin and compared them with diabetics who did not require insulin.

Diabetes
Representational image. Pixabay

Patients requiring insulin can be considered to have more severe diabetes and have a greater chance of experiencing elevated blood glucose in the perioperative period, Waddell said.

Patients with higher blood glucose over the previous three months — as measured by Hemoglobin A1c — were more likely to experience post-operative hyperglycemia regardless of which group they were in.

Also Read- Excessive Hygiene Can Cause Antibiotic Resistance, Says Study

Hemoglobin A1c above 6.59 for people with insulin-dependent diabetes and 6.6 without the condition was associated with an elevated risk for post-operative hyperglycemia.

However, despite the increased risk for elevation in blood sugar after surgery, the incidence of post-operative joint infections did not differ between the two groups of patients. The author also noted that a limitation of the study was that it was underpowered to detect the risk of infection. (IANS)